X4 Pharmaceuticals (XFOR) Tops Q4 EPS by 5c
X4 Pharmaceuticals (NASDAQ: XFOR) reported Q4 EPS of ($0.10), $0.05 better than the analyst estimate of ($0.15).
For earnings history and earnings-related data on X4 Pharmaceuticals (XFOR) click here.
X4 Pharmaceuticals (NASDAQ: XFOR) reported Q4 EPS of ($0.10), $0.05 better than the analyst estimate of ($0.15).
For earnings history and earnings-related data on X4 Pharmaceuticals (XFOR) click here.